WallStreetZenWallStreetZen

NASDAQ: LAB
Standard Biotools Inc Earnings & Revenue

LAB past revenue growth

How has LAB's revenue growth performed historically?
Company
31.27%
Industry
2.28%
Market
19.07%
LAB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LAB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LAB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LAB earnings and revenue history

Current Revenue
$126.8M
Current Earnings
-$136.0M
Current Profit Margin
-107.3%

LAB Return on Equity

Current Company
-295.4%
Current Industry
-10.3%
Current Market
28.2%
LAB's Return on Equity (-295.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LAB announces earnings.

LAB Return on Assets

Current Company
-30.3%
Current Industry
6.4%
LAB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LAB Return on Capital Employed

Current Company
-13.14%
Current Industry
11.4%
LAB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LAB vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LAB$126.76M-$76.45M-$135.98M+1.47%N/A
CDNA$275.11M-$175.06M-$183.19M+25.46%N/A
FLGT$287.53M-$127.63M-$165.95M+67.10%N/A
OPK$799.60M-$128.11M-$252.43M-3.55%N/A
CSTL$250.73M-$17.87M-$30.80M+55.20%N/A

LAB earnings dates

Next earnings date
Jul 31, 2024

Standard Biotools Earnings & Revenue FAQ

What were LAB's earnings last quarter?

On Invalid Date, Standard Biotools (NASDAQ: LAB) reported Q1 2024 earnings per share (EPS) of -$0.27, up 28.57% year over year. Total Standard Biotools earnings for the quarter were -$78.17 million. In the same quarter last year, Standard Biotools's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Standard Biotools stock.

What was LAB's earnings growth in the past year?

As of Q3 2024, Standard Biotools's earnings has grown year over year. Standard Biotools's earnings in the past year totalled -$135.98 million.

What is LAB's earnings date?

Standard Biotools's earnings date is Invalid Date. Add LAB to your watchlist to be reminded of LAB's next earnings announcement.

What was LAB's revenue last quarter?

On Invalid Date, Standard Biotools (NASDAQ: LAB) reported Q1 2024 revenue of $45.54 million up 81.3% year over year. In the same quarter last year, Standard Biotools's revenue was $25.12 million.

What was LAB's revenue growth in the past year?

As of Q3 2024, Standard Biotools's revenue has grown 31.27% year over year. This is 28.99 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 2.28%. Standard Biotools's revenue in the past year totalled $126.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.